-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Q1 EPS Estimates for Myriad Genetics Reduced by Analyst
Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) – Equities research analysts at Leerink Partnrs reduced their Q1 2025 earnings estimates for shares of Myriad Genetics in a research report issued on Tuesday, February 25th. Leerink Partnrs analyst P. Souda now anticipates that the company will post earnings of ($0.18) per share for the quarter, down […]
Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) – Equities research analysts at Leerink Partnrs reduced their Q1 2025 earnings estimates for shares of Myriad Genetics in a research report issued on Tuesday, February 25th. Leerink Partnrs analyst P. Souda now anticipates that the company will post earnings of ($0.18) per share for the quarter, down […]
